(PRWEB UK) 9 January 2013
Growth in the prefilled syringes market if manufacturers can solve current product problems, says the report Innovation in the Prefilled Syringe Market: Biologics and Autoinjection Devices Shaping Future R&D Trends.
According to the report, the development of injectable biologic therapies is a major factor for the future prospects of prefilled syringes, as many peptides contained in oral formulations are broken down too quickly in the stomach, compromising their effectiveness.
Currently, many biologic therapies are incompatible with the silicone used in glass syringes, necessitating a move to plastic variations and the development of new polymers and coatings that minimise reactions between the syringe material and the drug that cause contamination.
Glass has been the primary material in syringe manufacturing for decades, but is slowly being replaced as the advantages of polymer-based alternatives become apparent. Other than the possibility of product contamination, glass syringes are more fragile and are prone to flaking, but existing plastic versions are not without their own faults.
Read more here:Innovation in the Prefilled Syringe Market: Biologics and Autoinjection Devices Shaping Future R&D Trends